Laserfiche WebLink
4. "Counsel" shall mean the undersigned private attorneys representing the Political <br />Subdivisions. <br />5. "The Parties" shall mean the Commonwealth of Virginia, the Political <br />Subdivisions, and Counsel. <br />6. "Negotiating Committee" shall mean a three - member representative group of the <br />Parties. The Commonwealth shall be represented by the Virginia Attorney General <br />or his designees. The Political Subdivisions and Counsel shall be represented by <br />W Edgar Spivey of Kaufman & Canoles, P.C. or his designee, and J. Burton <br />LeBlanc of Baron & Budd, P.C. or his designee. <br />7. "Settlement" shall mean the negotiated resolution of legal or equitable claims <br />against a Pharmaceutical Supply Chain Participant named in Complaints filed by <br />all the Political Subdivisions in court on or before April 30, 2020 when that <br />resolution has been jointly entered into by the Commonwealth, the Political <br />Subdivisions, and Counsel. "Settlement" also shall include the approval by a <br />United States Bankruptcy Court of a plan of reorganization or liquidation of a <br />Pharmaceutical Supply Chain Participant, or any other determination, ruling, or <br />decision by a United States Bankruptcy Court, in which Iegal or equitable claims <br />against the Pharmaceutical Supply Chain Participant by the Commonwealth and the <br />Political Subdivisions are settled, adjudicated, released, or otherwise resolved. <br />8. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as <br />defined in this MOU. <br />9. "Approved Abatement Purposes" shall mean efforts to treat, prevent, or reduce <br />opioid use disorder or the misuse of opioids or to otherwise abate or remediate the <br />2 <br />